Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC,
Actavis Inc., and Dynavax Technologies Corp.
Editor Note: For more information about this release, please scroll to bottom
LONDON, October 1, 2013
LONDON, October 1, 2013 /PRNewswire/ --
The U.S. equity market posted losses on Monday, September 30, 2013. The S&P
500 ended the day at 1,681.55, down 0.60%; the Dow Jones Industrial Average
closed at 15,129.67, down 0.84%; and the NASDAQ Composite finished at
3,771.48, down 0.27%. Shares in healthcare-drug makers sector edged lower,
tracking losses in the broader market. The major movers in the sector included
AVANIR Pharmaceuticals Inc. (NASDAQ: AVNR), Warner Chilcott PLC (NASDAQ:
WCRX), Actavis Inc. (NYSE: ACT), and Dynavax Technologies Corporation (NASDAQ:
DVAX). All these companies are tracked by AAAResearchReports.com. Free
in-depth technical analysis on AVNR, WCRX, ACT, and DVAX are currently
available upon signing up at:
Shares in AVANIR Pharmaceuticals Inc. fell sharply on Monday, extending the
losses from the previous trading sessions. The company's shares traded between
$4.16 and $4.28 before finishing the day 1.63% lower at $4.23. A total of 1.72
million shares were fluctuated, which is below the daily average volume of
3.00 million. Despite Monday's losses, AVANIR Pharmaceuticals Inc.'s stock is
trading above its 200-day moving average of $3.64. Further, the company's
shares have declined by 2.74% in the previous three trading sessions,
underperforming the S&P 500 which has fallen by 0.66% during the same period.
Sign up for free technical analysis on AVNR at:
On Monday, Warner Chilcott PLC's stock fell by 0.78%, reversing some of the
gains from the previous trading session. The company's shares ended the day at
$22.93 after oscillating between $22.72 and $23.05. A total of 24.39 million
shares were traded, which is significantly above the daily average volume of
3.10 million. Despite Monday's pullback, Warner Chilcott PLC's shares have
gained 6.90% in the last one month and 15.17% in the previous three months,
outperforming the S&P 500 which has advanced 2.97% and 4.69% during the
respective periods. Furthermore, the company's stock is trading near its
52-week high of $23.29 as well as above its 50-day and 200-day moving averages
of $21.50 and $16.92, respectively. Download free report on WCRX by
Actavis Inc.'s stock edged lower on Monday, tracking losses in the broader
market. The company's shares traded between $142.06 and $144.11 before
finishing the day 0.21% lower at $144.00. A total of 9.67 million shares were
traded, which is significantly above the daily average volume of 1.19 million.
Despite Monday's losses, the company's shares have gained 6.52% in the last
one month and 14.09% in the previous three months, compared to a gain of 2.97%
and 4.69% in the S&P 500 during the respective periods. Further, Actavis
Inc.'s stock is trading close to its 52-week high of $145.50 as well as above
its 50-day and 200-day moving averages of $135.20 and $109.97, respectively.
The free report on ACT can be downloaded by signing up now at:
Shares in Dynavax Technologies Corp. plummeted on Monday, reversing all of the
gains from the previous trading sessions. The company's shares ended the day
at $1.19, which is 6.30% lower than the previous day's price of $1.27. The
company's shares vacillated between $1.18 and $1.28 during the trading
session. A total of 2.45 million shares were traded, which is above the daily
average volume of 2.38 million. Despite Monday's sharp decline, the company's
shares have gained 8.18% in the previous three months, outperforming the S&P
500 which had gained 4.69% during the same period. Further, Dynavax
Technologies Corp.'s stock is trading below its 50-day and 200-day moving
averages of $1.28 and $2.05, respectively. A free report on DVAX can be
accessed by registering at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Phone #: +1(646)396-9126, Contact Name: Peter F. Jones Email ID:
Press spacebar to pause and continue. Press esc to stop.